Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations

Vaccine

Volumn 25, Issue 18, 2007, Pages 3658-3668

  Pinitkiatisakul, Sunan ^a   Friedman, Mikaela ^b   Wikman, Maria ^b   Mattsson, Jens G ^a   Lövgren Bengtsson, Karin ^c   Ståhl, Stefan ^b   Lundén, Anna ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b ALBANOVA UNIVERSITY CENTER   (Sweden)

^c Isconova AB   (Sweden)

Author keywords

Iscom; Neospora caninum; Recombinant immunogen

Indexed keywords

ANTIBODY; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; ISCOM; MEMBRANE ANTIGEN; NEOSPORA CANINUM SRS2 ANTIGEN; NICKEL; PROTOZOAL DNA; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BIOTINYLATION; BRAIN INFECTION; BRAIN PROTECTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ESCHERICHIA COLI; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; NEOSPORA CANINUM; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SPLEEN CELL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; COCCIDIOSIS; FEMALE; ISCOMS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEOSPORA; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN;

EID: 34147188155     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.074     Document Type: Article

References (37)

1. Dubey J.P. Review of Neospora caninum and neosporosis in animals. Korean J Parasitol 41 1 (2003) 1-16
2. Gondim L.F., McAllister M.M., Pitt W.C., and Zemlicka D.E. Coyotes (Canis latrans) are definitive hosts of Neospora caninum. Int J Parasitol 34 2 (2004) 159-161
3. Atkinson R., Harper P.A., Ryce C., Morrison D.A., and Ellis J.T. Comparison of the biological characteristics of two isolates of Neospora caninum. Parasitology 118 4 (1999) 363-370
4. Lundén A., Wright S., Allen J.E., and Buxton D. Immunisation of mice against neosporosis. Int J Parasitol 32 7 (2002) 867-876
5. Buxton D., Wright S., Maley S.W., Rae A.G., Lundén A., and Innes E.A. Immunity to experimental neosporosis in pregnant sheep. Parasite Immunol 23 2 (2001) 85-91
6. Innes E.A., Wright S.E., Maley S., Rae A., Schock A., Kirvar E., et al. Protection against vertical transmission in bovine neosporosis. Int J Parasitol 31 13 (2001) 1523-1534
7. Liddell S., Jenkins M.C., Collica C.M., and Dubey J.P. Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination. J Parasitol 85 6 (1999) 1072-1075
8. Baszler T.V., McElwain T.F., and Mathison B.A. Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease. Clin Diagn Lab Immunol 7 6 (2000) 893-898
9. Cannas A., Naguleswaran A., Müller N., Gottstein B., and Hemphill A. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol 89 1 (2003) 44-50
10. Alaeddine F., Keller N., Leepin A., and Hemphill A. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J Parasitol 91 3 (2005) 657-665
11. Cannas A., Naguleswaran A., Müller N., Eperon S., Gottstein B., and Hemphill A. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 126 4 (2003) 303-312
12. Nishikawa Y., Inoue N., Xuan X., Nagasawa H., Igarashi I., Fujisaki K., et al. Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection. Vaccine 19 11-12 (2001) 1381-1390
13. Nishikawa Y., Xuan X., Nagasawa H., Igarashi I., Fujisaki K., Otsuka H., et al. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine 19 13-14 (2001) 1710-1716
14. Haldorson G.J., Mathison B.A., Wenberg K., Conrad P.A., Dubey J.P., Trees A.J., et al. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice. Int J Parasitol 35 13 (2005) 1407-1415
15. Morein B., Lövgren-Bengtsson K., and Cox J. In: Kaufmann S.H.E. (Ed). General principles of vaccinology (1996), Walter de Gruyter, New York 243-263
16. Delbecq S., Hadj-Kaddour K., Randazzo S., Kleuskens J., Schetters T., Gorenflot A., et al. Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens. Vaccine 24 5 (2006) 613-621
17. Wikman M., Friedman M., Pinitkiatisakul S., Andersson C., Hemphill A., Lövgren-Bengtsson K., et al. General strategies for efficient adjuvant incorporation of recombinant subunit immunogens. Vaccine 23 17-18 (2005) 2331-2335
18. Morein B., and Lövgren-Bengtsson K. Immunomodulation by iscoms, immune stimulating complexes. Methods 19 1 (1999) 94-102
19. Sjölander A., Cox J.C., and Barr I.G. ISCOMs: an adjuvant with multiple functions. J Leukoc Biol 64 6 (1998) 713-723
20. Andersson C., Wikman M., Lövgren-Bengtsson K., Lundén A., and Ståhl S. In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation. J Immunol Methods 255 1-2 (2001) 135-148
21. Wikman M., Friedman M., Pinitkiatisakul S., Hemphill A., Lövgren-Bengtsson K., Lundén A., et al. Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens. Biotechnol Appl Biochem 41 2 (2005) 163-174
22. Pinitkiatisakul S., Mattsson J.G., Wikman M., Friedman M., Bengtsson K.L., Ståhl S., et al. Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Vet Parasitol 129 1-2 (2005) 25-34
23. Sjölander A., Hansson M., Lövgren K., Wåhlin B., Berzins K., and Perlmann P. Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA. Parasite Immunol 15 6 (1993) 355-359
24. Björkman C., and Lundén A. Application of iscom antigen preparations in ELISAs for diagnosis of Neospora and Toxoplasma infections. Int J Parasitol 28 1 (1998) 187-193
25. Schares G., Dubremetz J.F., Dubey J.P., Bärwald A., Loyens A., and Conraths F.J. Neospora caninum: identification of 19-, 38-, and 40-kDa surface antigens and a 33-kDa dense granule antigen using monoclonal antibodies. Exp Parasitol 92 2 (1999) 109-119
26. Björkman C., and Hemphill A. Characterization of Neospora caninum iscom antigens using monoclonal antibodies. Parasite Immunol 20 2 (1998) 73-80
27. Dubey J.P., Hattel A.L., Lindsay D.S., and Topper M.J. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc 193 10 (1988) 1259-1263
28. Lundén A., Marks J., Maley S.W., and Innes E.A. Cellular immune responses in cattle experimentally infected with Neospora caninum. Parasite Immunol 20 11 (1998) 519-526
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
30. Müller N., Zimmermann V., Hentrich B., and Gottstein B. Diagnosis of Neospora caninum and Toxoplasma gondii infection by PCR and DNA hybridization immunoassay. J Clin Microbiol 34 11 (1996) 2850-2852
31. Liddell S., Jenkins M.C., and Dubey J.P. A competitive PCR assay for quantitative detection of Neospora caninum. Int J Parasitol 29 10 (1999) 1583-1587
32. Khan I.A., Schwartzman J.D., Fonseka S., and Kasper L.H. Neospora caninum: role for immune cytokines in host immunity. Exp Parasitol 85 1 (1997) 24-34
33. Long M.T., Baszler T.V., and Mathison B.A. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum. J Parasitol 84 2 (1998) 316-320
34. Baszler T.V., Long M.T., McElwain T.F., and Mathison B.A. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int J Parasitol 29 10 (1999) 1635-1646
35. Innes E.A., Andrianarivo A.G., Björkman C., Williams D.J.L., and Conrad P.A. Immune responses to Neospora caninum and prospects for vaccination. Trends Parasitol 18 11 (2002) 497-504
36. Long M.T., and Baszler T.V. Neutralization of material IL-4 modulates congenital protozoal transmission:comparison of innate versus acquired immune responses. J Immunol 164 9 (2000) 4768-4774
37. Wilchek M., and Bayer E.A. Introduction to avidin-biotin technology. Methods Enzymol 184 (1990) 5-13